Joseph C. Murray

Also affiliated with Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma”.

Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100139

N/A

2.3DataRank · unranked

79 citations

Daniel C. Bruhm, Noushin Niknafs, James R. White, Xiaoshan M. Shao, John-William Sidhom +19 more

Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004688

N/A

0DataRank · unranked

139 citations

Jenna VanLiere Canzoniero, Samuel Rosner, Guangfan Zhang, James R. White, Zineb Belcaid +22 more

Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy

The Oncologist(2022)10.1093/oncolo/oyac140

N/A

0DataRank · unranked

20 citations

Joseph C. Murray, Kevin J. Psoter, Jiajia Zhang, Durrant Barasa, Julie R. Brahmer +14 more

Sex-specific differences in immunogenomic features of response to immune checkpoint blockade

Frontiers in Oncology(2022)10.3389/fonc.2022.945798

N/A

0DataRank · unranked

13 citations

Xiaoshan M. Shao, Noushin Niknafs, Archana Balan, Gavin Pereira, Kristen A. Marrone +12 more

Persistent mutation burden drives sustained anti-tumor immune responses

Nature Medicine(2023)10.1038/s41591-022-02163-w

N/A

0DataRank · unranked

143 citations

Archana Balan, Christopher Cherry, Karlijn Hummelink, Kim Monkhorst, Xiaoshan M. Shao +16 more

Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005924

N/A

0DataRank · unranked

112 citations

Joseph C. Murray, Jenna VanLiere Canzoniero, Blair V. Landon, Jennifer Jackson, Susan Scott +5 more

Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1469

N/A

0DataRank · unranked

34 citations

Lavanya Sivapalan, Karlijn Hummelink, Archana Balan, James R. White, Noushin Niknafs +28 more

Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.23.546338

N/A

0DataRank · unranked

3 citations

Lavanya Sivapalan, Karlijn Hummelink, Archana Balan, James R. White, Noushin Niknafs +25 more

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7

N/A

0DataRank · unranked

165 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001282

N/A

0DataRank · unranked

166 citations

Valsamo Anagnostou, Tricia R. Cottrell, Kellie N. Smith, Franco Verde, Marianna Zahurak +27 more

Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis

Arthritis Research & Therapy(2025)10.1186/s13075-025-03546-3

N/A

0DataRank · unranked

5 citations

Ami A. Shah, Clifton O. Bingham, Jennifer H. Elisseeff, Joseph C. Murray, Julie R. Brahmer +5 more